US Stock MarketDetailed Quotes

ACRV Acrivon Therapeutics

Watchlist
  • 10.000
  • +1.540+18.20%
Close Apr 29 16:00 ET
  • 9.892
  • -0.108-1.08%
Post 16:33 ET
308.75MMarket Cap-3649P/E (TTM)

Acrivon Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Acrivon Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

--

Revenue(YoY)

0.00

0.00%
EPS(YoY)

-0.87

-8.75%
Analyst Rating

Strong Buy

Apr 29, 2024

Acrivon Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 0.000--
--2024/Q1-- / 0.000--
--2023/Q40.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2023/Q10.000 / 0.000--
--2022/Q40.000 / 0.000--
--2022/Q30.000 / 0.000--
--------
--------

Unlock Free Earnings Estimates

Acrivon Therapeutics Earnings Reports

  • Acrivon Therapeutics | 10-K: Annual report

    Mar 28 19:39

  • Acrivon Therapeutics: Q3 2023 Earnings Report

    Nov 9, 2023 21:02

  • Acrivon Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 11, 2023 19:11

  • Acrivon Therapeutics | 10-Q: Quarterly report

    May 9, 2023 20:05

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 29, 2024

    Strong Buy

    • Buy

      88.89%

    • Hold

      11.11%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg